AptarGroup completed acquisition of Nanopharm and Gateway Analytical for $50m.

AptarGroup, a healthcare packaging provider, completed the acquisition of Nanopharm and Gateway Analytical, pharmaceutical services companies, for $50m. “These strategic investments further strengthen our best in class Pharma business and increase our ability to add to our long-term growth pipeline by adding depth to our service offerings. The expertise of two established leaders, Nanopharm, a leader in inhalation and nasal drug development services, and Gateway, a leader in particulate detection and analysis for the injectables market, are complementary to our existing laboratory and analytical services and will bring additional value to our customers as they navigate the challenging regulatory landscape and seek to bring their products to market faster,” Stephan Tanda, Aptar Pharma President and CEO.